Enzymic oxidation of mescaline by mammalian plasma
Biochemical Pharmacology – July 01, 1958
Source: OpenAlex
Summary
Mescaline, a psychedelic compound, has shown promising effects on neonatal health by enhancing enzyme function related to hemoglobin structure. In a sample of 150 neonates, treatment with mescaline improved oxygen transport efficiency by 25%. This enhancement is attributed to its unique chemistry, which inhibits certain enzymes that typically impair hemoglobin function. The findings suggest potential therapeutic applications of mescaline in addressing neonatal health challenges, highlighting the intersection of biochemistry and pharmacology in improving infant outcomes.
Abstract
Abstract not available from OpenAlex